Quality of life (QoL) patient-reported outcomes (PROs) data from pivotal first-line trials in metastatic colorectal cancer (mCRC) are poor. The Valentino study showed that de-escalation to single-agent panitumumab after 4-month induction with panitumumab-FOLFOX is inferior to panitumumab-5-FU/LV in patients with RAS wild-type mCRC, although slightly reducing toxicity. We report QoL, a secondary end-point.
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study / Raimondi, Alessandra; Di Maio, Massimo; Morano, Federica; Corallo, Salvatore; Lonardi, Sara; Antoniotti, Carlotta; Rimassa, Lorenza; Sartore-Bianchi, Andrea; Tampellini, Marco; Ritorto, Giuliana; Murialdo, Roberto; Clavarezza, Matteo; Zaniboni, Alberto; Adamo, Vincenzo; Tomasello, Gianluca; Petrelli, Fausto; Antonuzzo, Lorenzo; Giordano, Monica; Cinieri, Saverio; Longarini, Raffaella; Bergamo, Francesca; Niger, Monica; Antista, Maria; Peverelli, Giorgia; de Braud, Filippo; Di Bartolomeo, Maria; Pietrantonio, Filippo. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 1879-0852. - STAMPA. - 135:(2020), pp. 230-239. [10.1016/j.ejca.2020.04.048]
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study
Antonuzzo, Lorenzo;Di Bartolomeo, Maria;
2020
Abstract
Quality of life (QoL) patient-reported outcomes (PROs) data from pivotal first-line trials in metastatic colorectal cancer (mCRC) are poor. The Valentino study showed that de-escalation to single-agent panitumumab after 4-month induction with panitumumab-FOLFOX is inferior to panitumumab-5-FU/LV in patients with RAS wild-type mCRC, although slightly reducing toxicity. We report QoL, a secondary end-point.
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0959804920302501-main.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
1.46 MB
Formato
Adobe PDF
|
1.46 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
